Roche, Prothena Form $600M Parkinson's Partnership
Biotech companies Roche Holding Ltd. and Prothena Corp. PLC will partner up to the tune of $600 million to develop and sell treatments for Parkinson's disease, the companies said Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article